1. AP-1 Is a Key Regulator of Proinflammatory Cytokine TNFα-mediated Triple-negative Breast Cancer Progression
- Author
-
Philip Jonsson, Chunyan Zhao, Huan He, Yichun Qiao, Indranil Sinha, and Karin Dahlman-Wright
- Subjects
0301 basic medicine ,Proto-Oncogene Proteins c-jun ,Cell Adhesion Molecules, Neuronal ,Triple Negative Breast Neoplasms ,Biology ,Biochemistry ,Proinflammatory cytokine ,Metastasis ,Transcriptome ,03 medical and health sciences ,0302 clinical medicine ,Breast cancer ,Cell Line, Tumor ,medicine ,Humans ,Nerve Growth Factors ,Molecular Biology ,Triple-negative breast cancer ,Tumor Necrosis Factor-alpha ,NF-kappa B ,Cancer ,Cell Biology ,medicine.disease ,Gene Expression Regulation, Neoplastic ,Transcription Factor AP-1 ,030104 developmental biology ,Cistrome ,Tumor progression ,030220 oncology & carcinogenesis ,Cancer research ,Additions and Corrections ,Female ,Chromosomes, Human, Pair 4 - Abstract
Triple-negative breast cancer (TNBC) represents a highly aggressive form of breast cancer with limited treatment options. Proinflammatory cytokines such as TNFα can facilitate tumor progression and metastasis. However, the mechanistic aspects of inflammation mediated TNBC progression remain unclear. Using ChIP-seq, we demonstrate that the cistrome for the AP-1 transcription factor c-Jun is comprised of 13,800 binding regions in TNFα-stimulated TNBC cells. In addition, we show that c-Jun regulates nearly a third of the TNFα-regulated transcriptome. Interestingly, high expression level of the c-Jun-regulated pro-invasion gene program is associated with poor clinical outcome in TNBCs. We further demonstrate that c-Jun drives TNFα-mediated increase of malignant characteristics of TNBC cells by transcriptional regulation of Ninj1. As exemplified by the CXC chemokine genes clustered on chromosome 4, we demonstrate that NF-κB might be a pioneer factor required for the regulation of TNFα-inducible inflammatory genes, whereas c-Jun has little effect. Together, our results uncover AP-1 as an important determinant for inflammation-induced cancer progression, rather than inflammatory response.
- Published
- 2016
- Full Text
- View/download PDF